In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Medarex and Neuro Announce Partnership To Develop Antibody Therapeutics
Medarex and Xerion antibody deal
Medarex and Northwest Biotherapeutics Announce Alliance To Develop New Cancer Therapies
Medarex and Compugen Announce Therapeutic Antibody Co-Development Agreement
Medarex and Compugen announce therapeutic antibody co-development agreement
Medarex and Lonza Sign Collaboration Agreement for the Supply of Antibody-Based Products
Medarex and Lonza Sign Collaboration Agreement for the Supply of Antibody-Based Products
Genmab and Medarex Announce Collaboration
BioWa and Medarex announce expansion of licensing agreement for BioWa's potelligent™ technology
Oxford Genome Sciences Announces New Therapeutic Antibody Deal with Medarex